SEC Form 4 · accession 0001209191-15-035488

Cidara Therapeutics, Inc. · CDTX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Apr 20, 2015

Accepted (ET)

Apr 22, 2015 · 2:45 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001610618

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Apr 20, 2015	P	200,000	$16.00	A	200,000	I	By limited partnership
Common Stock^F2,F1	Apr 20, 2015	C	1,156,813	—	A	1,356,813	I	By limited partnership

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Convertible Preferred Stock^F1,F2	—	Apr 20, 2015	C	1,156,813	D	—	—	Common Stock	1,156,813	0	I

F1Shares are held by InterWest Partners X, LP. InterWest Management Partners X, LLC has sole voting and investment control over the shares owned by InterWest X, LP. The managing directors and venture members of InterWest Management Partners X, LLC have shared voting and investment control over the shares owned by InterWest X, LP. The reporting person is a managing director of InterWest Management Partners X, LLC and disclaims beneficial ownership of the shares owned by InterWest Partners X, LP, except to the extent of her pro rata partnership interest therein.
F2In connection with the Issuer's initial public offering, the preferred stock automatically converted into shares of the Issuer's common stock at the rate of 1 share of common stock for each 25.4 shares of preferred stock. The preferred stock had no expiration date.

This filing serves as an exit report in connection with the Reporting Person's resignation from the Issuer's Board of Directors effective 4/20/2015.